Fresenius Medical Care, maker of the dialysis drug GranuFlo, gives dialysis to 167,000 people in the U.S. But only 201 have filed a GranuFlo lawsuit.
Our work on dialysis lawsuits has led me to a recent suspicion: I believe there are probably hundreds, if not thousands, of people who could collect a large cash award in a GranuFlo lawsuit, but they simply don’t know they qualify. But we’ll help you find out free-of-charge if you fill out our free GranuFlo Lawsuit Case Review Form.
What is GranuFlo?
GranuFlo was a drug that was used by Fresenius Medical Care and other companies during the process of dialysis. It seems unlikely that most dialysis patients knew the name of the drugs that were used during dialysis.
GranuFlo was recalled March 29, 2012 in a FDA Class I recall.
Class I recalls are the most serious type of recall; it means that patients are likely to suffer serious injuries or death if the drug is not recalled.
Fresenius Medical Care, maker of GranuFlo, has 167,000 dialysis patients.
Fresenius Medical Care, in a press release, said it has more than 167,000 dialysis patients in the U.S. It’s almost certain that the dialysis drug manufactured by Fresenius was used on all its dialysis patients. Additionally, GranuFlo was sold to other dialysis providers. So there were at least 167,000, and perhaps many more, patients who had dialysis using the drug GranuFlo.
Only 201 GranuFlo lawsuits have been filed in the federal MDL GranuFlo litigation
If at least 167,000 dialysis patients were exposed to a drug that the FDA recalled because it could cause serious injury or death, simple logic suggests that there are many more people who suffered heart problems or death due to GranuFlo. The most reasonable explanation for the small number of GranuFlo lawsuits seems (to me) to be this: the dialysis patients simply didn’t know their injuries or death were caused by GranuFlo.